CANTARELLA, GIUSEPPINA
 Distribuzione geografica
Continente #
NA - Nord America 6.151
EU - Europa 2.643
AS - Asia 2.435
SA - Sud America 538
AF - Africa 332
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 9
Totale 12.118
Nazione #
US - Stati Uniti d'America 5.914
SG - Singapore 1.162
IT - Italia 952
CN - Cina 908
IE - Irlanda 573
BR - Brasile 467
UA - Ucraina 449
CA - Canada 204
CI - Costa d'Avorio 183
RU - Federazione Russa 148
DE - Germania 136
SN - Senegal 110
VN - Vietnam 90
SE - Svezia 89
KR - Corea 82
GB - Regno Unito 70
IN - India 55
FR - Francia 36
BE - Belgio 32
CH - Svizzera 27
NL - Olanda 25
FI - Finlandia 24
AR - Argentina 22
BD - Bangladesh 21
MX - Messico 21
PL - Polonia 20
ES - Italia 16
JP - Giappone 14
IQ - Iraq 13
ID - Indonesia 12
NG - Nigeria 12
UZ - Uzbekistan 12
AT - Austria 11
GR - Grecia 11
TR - Turchia 10
CO - Colombia 9
EU - Europa 9
EC - Ecuador 8
HK - Hong Kong 8
NZ - Nuova Zelanda 8
PE - Perù 8
VE - Venezuela 8
ZA - Sudafrica 8
CZ - Repubblica Ceca 7
LT - Lituania 7
PK - Pakistan 7
IL - Israele 6
LB - Libano 6
MA - Marocco 6
SA - Arabia Saudita 6
IR - Iran 5
UY - Uruguay 5
AL - Albania 4
CL - Cile 4
JO - Giordania 4
PY - Paraguay 4
BO - Bolivia 3
DZ - Algeria 3
EG - Egitto 3
KE - Kenya 3
PH - Filippine 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
HN - Honduras 2
JM - Giamaica 2
RS - Serbia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
BH - Bahrain 1
BW - Botswana 1
BZ - Belize 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PR - Porto Rico 1
Totale 12.118
Città #
Dallas 1.255
Santa Clara 859
Singapore 648
Chandler 573
Dublin 573
Jacksonville 463
Chicago 352
Boardman 253
Catania 229
Ashburn 189
Abidjan 183
Hefei 158
Cambridge 155
Lawrence 155
Nanjing 155
Toronto 151
Andover 145
Beijing 142
Civitanova Marche 139
Dakar 110
San Mateo 82
Seoul 81
Los Angeles 80
Des Moines 64
Wilmington 58
Grafing 52
Hebei 47
Nanchang 47
São Paulo 46
Shenyang 43
Bremen 40
Jiaxing 37
Bronte 36
Ho Chi Minh City 36
Brussels 32
Palermo 30
Saint Petersburg 30
Changsha 29
New York 28
Ottawa 27
Rome 26
Brooklyn 24
Council Bluffs 22
Houston 22
Munich 22
Tianjin 22
Buffalo 19
Seattle 19
Milan 18
Pune 18
The Dalles 18
Columbus 17
Lappeenranta 17
Moscow 16
Washington 15
Denver 14
Montreal 14
San Francisco 14
Tokyo 14
Curitiba 13
Messina 13
Abuja 12
Norwalk 12
Redondo Beach 12
Stockholm 12
Belo Horizonte 11
Warsaw 11
Boydton 10
Campinas 10
Hangzhou 10
Hanoi 10
Jinan 10
Liberty Lake 10
Manchester 10
Brasília 9
Chennai 9
Poplar 9
Boston 8
Den Haag 8
Modica 8
Shanghai 8
Aci Catena 7
Amsterdam 7
Da Nang 7
Frankfurt Am Main 7
Gravina di Catania 7
Guangzhou 7
Hong Kong 7
Jakarta 7
Mumbai 7
Ningbo 7
Rio de Janeiro 7
Trecastagni 7
Atlanta 6
Dong Ket 6
Florence 6
Genoa 6
Guarulhos 6
London 6
Mascalucia 6
Totale 8.514
Nome #
Role of TNF Related Apoptosis Inducing Ligand in neurodegeneration. 200
Beneficial effects of curtailing immune susceptibility in an Alzheimer's disease model 142
The proinflammatory cytokine GITRL contributes to TRAIL-mediated neurotoxicity in the HCN-2 human neuronal cell line 132
L 'asse ipotalamo-ipofisi surrene in modelli sperimentali di artrite nel ratto 131
Anti-TRAIL monoclonal antibody-nanoparticle complexes: preliminary studies on macrophage cell line 129
Ampicillin plus ceftriaxone therapy against Enterococcus faecalis endocarditis: A case report, guidelines considerations, and literature review 129
Amylin prevents TRAIL-mediated apoptotic effects of reserpine in the rat gastric mucosa 126
Pharmacological enhancement of cholinergic neurotransmission alleviates neuroinflammation and improves functional outcomes in a triple transgenic mouse model of Alzheimer’s disease 125
Disease Modifying Strategies in Multiple Sclerosis: New Rays of Hope to Combat Disability? 120
CHF5074 protects SH-SY5Y human neuronal-like cells from amyloidbeta 25-35 and tumor necrosis factor related apoptosis inducing ligand toxicity in vitro 119
The biochemical and pharmacological properties of ozone: The smell of protection in acute and chronic diseases 118
Beneficial effects of choline alphoscerate on amyloid-β neurotoxicity in an in vitro model of alzheimer’s disease 116
Adrenomedullin modulates COX-2 and HGF expression in reserpine-injuried gastric mucosa in the rat 114
Amilyn prevents Trail-mediated apoptotic effects of Reserpine in the rat gastric mucosa 113
Sarilumab Administration in COVID-19 Patients: Literature Review and Considerations 112
Ampicillin Plus Ceftriaxone Regimen against Enterococcus faecalis Endocarditis: A Literature Review 106
Development of novel LP1-based analogues with enhanced delta opioid receptor profile 101
Neutralization of TNFSF10 ameliorates functional outcome in a murine model of Alzheimer's disease 101
Alternate mechanisms for the proapoptotic effect of cannabinoids in human melanoma cells: potential role of the membrane lipid raft 99
Thymic factors influence on behavior in rodents 98
Stem cells: Innovative therapeutic options for neurodegenerative diseases? 98
A web-based scoping review assessing the influence of smoking and smoking cessation on antidiabetic drug meabolism: implications for medication efficacy 97
Effects of pidotimod on the immune adrenal feedback in the aging rat 96
ALTERNATE SIGNALLING FOR TRAIL DEPENDENT NEUROTOXICITY IN HUMAN NEURONAL-LIKE CELLS IN VITRO 96
TRAIL-R Deficient Mice Are Protected from Neurotoxic Effects of Amyloid-β 95
Immunoneutralization of TRAIL improves inflammation and cognitive impairment in a triple transgenic mice model of Alzheimer's disease 93
Tumor necrosis factor-related apoptosis-inducing ligand reduces the expression of the neuroprotective Na+ /Ca2+ exchanger isoform NCX3 in human neuroblastoma SH-SY5Y cells 93
Oral Fosfomycin Formulation in Bacterial Prostatitis: New Role for an Old Molecule-Brief Literature Review and Clinical Considerations 91
Endocannabinoids inhibit release of nerve growth factor by inflammation-activated mast cells 91
Endothelial activation and injury by cigarette smoke exposure 91
Changes in the hypothalamus of the Lewis rat 91
Ischemic tolerance modulates TRAIL expression and its receptors and generates a neuroprotected phenotype 90
Alternate signalling for TRAIL dependent neurotoxicity in human neuronal-like cells in vitro 90
Approcci terapeutici innovativi nella malattia di Alzheimer 90
Intranasal Administration of a {TRAIL} Neutralizing Monoclonal Antibody Adsorbed in {PLGA} Nanoparticles and {NLC} Nanosystems: An In Vivo Study on a Mouse Model of Alzheimer's Disease 90
The antimitogenic effect of the cannabinoid receptor agonist WIN55212-2 on human melanoma cells is mediated by the membrane lipid raft 89
The immune system on the TRAIL of Alzheimer’s disease 89
Involvement of caspase 8 and c-FLIPL in the proangiogenic effects of the tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) 88
The CB(1)/CB(2) receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro 88
Neutralization of the apoptotic effects of the neurotoxic cytokine trail by a nanoparticle conjugated specific monoclonal antibody 88
Expression of Ca2+-independent and Ca2+-dependent phospholipases A(2) and cyclooxygenases in human melanocytes and malignant melanoma cell lines 88
Role of Microglia and Astrocytes in Alzheimer's Disease: From Neuroinflammation to Ca2+ Homeostasis Dysregulation 87
Neutralization of TRAIL death pathway protects human neuronal cell line from β−amyloid toxicity 86
TRAIL related neurotoxicity implies its interaction with the wnt pathway in human neuronal cells in vitro 86
Alternate mechanisms for the proapoptotic effect of cannabinoids in human melanoma cells: potential role of the membrane lipid raft 86
COMBINED MEASLES-HUMAN PAPILLOMA VACCINE 86
Decreased in vitro ACTH secretion in the lewis rat is associated to defective cyclic AMP accumulation 85
Cisplatin-induced kidney injury in the rat: l-carnitine modulates the relationship between MMP-9 and TIMP-3 84
Brimonidine is Neuroprotective in Animal Paradigm of Retinal Ganglion Cell Damage 84
The role of GITR/TRAIL interactions in neurodegenerative processes 83
Progress in the development of more effective and safer analgesics for pain management 83
) Corticotropin releasing hormone modulates production of nitric oxide from murine endothelioma cells 82
TRAI mediates amyloid beta toxicity on rat embryo neuronal cells 81
Cytokines and the nervous system 81
Effects of a Selective Sigma 1 Antagonist Compound on Inflammatory Pain 80
Anti-malarial drugs are not created equal for sars-cov-2 treatment: A computational analysis evidence 80
Levels of matrix metalloproteinases 1 and 2 in human gingival crevicular fluid during initial tooth movement 79
Tumor suppreessor CYLD is a NEMO-and TRAF2-binding deubiquitinating enzyme that negatively regulates NF-kB signalling 79
The Phospholipid Drug Glyceryl‐phosphoryl‐O‐serine Modulates Pituitary Adrenocorticotropin and Hypothalamic Corticotropin Releasing Hormone in vitro Secretion in the Aging Rat 79
L'asse ipotalamo-ipofisi-surrene in modelli sperimentali di artrite nel ratto 78
Composti utili per il trattamento di malattie neurodegenerative 78
Protective effects of estradiol on TRAIL-induced apoptosis in a human oligodendrocytic cell line: Evidence for multiple sites of interactions 77
Protective effects of the sigma agonist Pre-084 in the rat retina 77
Protective effects of amylin on reserpine-induced gastric damage in the rat 77
Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKγ upon receptor stimulation 76
Ruolo del sistema neuroendocrino nella regolazione della risposta immunitaria 76
Role of TRAIL in neurodegeneration 76
Increased ACTH and cortisol secretion after interleukin-1-alpha injection in the common marmoset (Callithrix Jacchus Jacchus) 76
Recombinant human TNF-binding protein-1 (rhTBP-1) treatment delays both clinical progression and motoneuron loss in the wobbler mouse by inhibiting the inflammatory pathway involving JNK and p38MAPK phosphorylation 75
Pharmacological Modulation of pituitary adrenocorticotrophin and hypothalamic CRH secretion in the aging rat in vitro Studies 75
Ocular pharmacological profile of hydrocortisone in dry eye disease 75
Taming Microglia in Alzheimer’s Disease: Exploring Potential Implications of Choline Alphoscerate via α7 nAChR Modulation 74
Effect of N-acetylcysteine on craving in substance use disorders (SUD): a meta-analysis of randomized controlled trials 74
In search of an ideal drug for safer treatment of obesity: The false promise of pseudoephedrine 74
Melatonin or Ramelteon for Delirium Prevention in the Intensive Care Unit: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 73
THE ROLE OF GITR IN THE REGULATION OF TRAIL PRO-INFLAMMATORY PROPERTY AFTER TRAUMATIC SPINAL CORD INJURY IN MICE: NEW POTENTIAL TARGETS FOR TREATMENT 72
Ipscs: A preclinical drug research tool for neurological disorders 72
Obesity as a Confounding Factor in the Diagnosis of Wilson’s Disease: Case Report of Two Siblings with the Same Genotype but Different Clinical Courses 71
Neutralization of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Reduces Spinal Cord Injury Damage in Mice 71
TRAIL INHIBITS ANGIOGENESIS STIMULATED BY VEGF EXPRESSION IN HUMAN GLIOBLASTOMA CELLS 70
Signaling pathways activated by receptors of the TNF/NGF receptor family.Solving a Pirandello play 70
The role of antioxidant supplement in immune system, neoplastic, and neurodegenerative disorders: A point of view for an assessment of the risk/benefit profile 69
Effects of pidotimod on the immune and the neuroendocrine system in the aging rat 69
Nerve growth factor (NGF) levels in follicular fluid of infertile patients undergoing to in vitro fertilization (IVF) cycle 69
Effetti dei neuropeptidi sulla produzione di ossido nitrico da parte di linee cellulari di endotelioma murino H5V 67
TRAIL interacts redundantly with nitric oxide in rat astrocytes: potential contribution to neurodegenerative processes 67
Toxicity of amyloid beta on embryo rat neuronal cells is mediated by tumor necrosis factor related apoptosis inducing ligand 66
Symptomatic hypocalcemia in an epileptic child treated with valproic acid plus lamotrigine: a case report 66
Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson’s Disease 66
Antibiotic Therapy Duration for Multidrug-Resistant Gram-Negative Bacterial Infections: An Evidence-Based Review 66
THE ROLE OF GITR IN THE REGULATION OF TRAIL PRO-INFLAMMATORY PROPERTY AFTER TRAUMATIC SPINAL CORD INJURY IN MICE 65
Neurotrophine follicular fluids concentration in infertility woman 65
Relevance of neuroendocrine-immune interactions. 64
Thymic hormones, cancer and behavioural adaptive responses 64
Expression of tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL) in brain cells of Alzheimer’s disease patients 64
INFLAMMATORY MEDIATORS AND THEIR RELEVANCE TO NEURODEGENERATION 63
TRAIL interacts redundantly with nitric oxide in rat glia in vitro 63
Tumor Necrosis Factor Related Apoptosis Inducing Ligand reduces the expression of the neuroprotective Na+/Ca++ exchanger isoform NCX3 in human cortical neurons. 63
Palmitoylethanolamide modulates mast cell-derived nerve growth factor-dependent angiogenesis 63
Divergent effects of corticotropin releasing hormone on endothelial cell inducibile nitric oxide synthase are associated with different expression of CRH type 1 and 2 receptors 62
Totale 8.722
Categoria #
all - tutte 43.571
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.571


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021549 0 0 0 0 230 28 66 1 113 2 73 36
2021/20221.108 140 144 1 19 162 9 155 42 126 5 64 241
2022/20231.916 173 66 38 211 170 313 9 363 457 15 61 40
2023/2024847 48 151 36 51 41 133 2 61 8 45 138 133
2024/20253.359 70 579 217 188 737 337 99 107 268 290 217 250
2025/20263.126 441 335 1.485 574 291 0 0 0 0 0 0 0
Totale 12.338